• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清铁蛋白与N末端脑钠肽前体联合检测在1岁以上儿童川崎病评估中的临床价值

Clinical value of combined detection of serum ferritin and N-terminal pro-brain natriuretic peptide in the assessment of Kawasaki disease in children over 1 year of age.

作者信息

Liu Zhen-Qing, Jia Wan-Yu, Li Peng, Song Chun-Lan

机构信息

Emergency medicine department, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, No. 1, South University Road, Erqi District, Zhengzhou, 450052, Henan, China.

出版信息

Ital J Pediatr. 2025 Jul 15;51(1):229. doi: 10.1186/s13052-025-02076-7.

DOI:10.1186/s13052-025-02076-7
PMID:40660372
Abstract

BACKGROUND

To compare the expression levels of serum ferritin and plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) in children over 1 year with Kawasaki disease (KD) and explore the early predictive value of the combined detection of these two indicators for the occurrence of intravenous immunoglobulin (IVIG) resistance and coronary artery lesions (CALs) in KD patients.

METHODS

A total of 320 children over 1 year of age with KD were retrospectively studied. All participants had peripheral blood samples collected at specific times to test laboratory indicators such as serum ferritin and NT-proBNP. The patients were divided into an IVIG-resistant group and an IVIG-responsive group on the basis of the initial IVIG treatment effect. According to the results of cardiac ultrasound, the patients were divided into a CAL group and a non-CAL group. SPSS 25.0 software was used for data analysis. Receiver operating characteristic (ROC) curves were used to evaluate the early diagnostic efficacy of various indicators for IVIG resistance and CALs in KD patients.

RESULTS

Logistic regression analysis revealed that the neutrophil percentage and duration of fever before initial IVIG were independent influencing factors of IVIG resistance in KD patients. IVIG resistance, duration of fever before initial IVIG, and serum albumin level were found to be independent influencing factors of CALs. ROC curve analysis revealed that the area under the curve (AUC) of NT-proBNP for identifying IVIG resistance in KD patients was 0.698. When the cutoff value of NT-proBNP was 419.6 pg/mL, the diagnostic efficacy for IVIG resistance in KD patients was the highest, with a sensitivity of 81.3% and a specificity of 53.0%. The ROC curve analysis revealed that the AUC of NT-proBNP combined with serum ferritin for identifying CALs in KD patients was 0.666, and the diagnostic efficiency of CALs was the highest.

CONCLUSIONS

In children over 1 year of age with KD, the level of NT-proBNP could be used as an early predictor of IVIG resistance and CALs, and the serum ferritin level could be used as an early predictor of CALs. The diagnostic efficacy of CALs can be further improved when NT-proBNP and serum ferritin are jointly detected.

摘要

背景

比较1岁以上川崎病(KD)患儿血清铁蛋白和血浆N末端脑钠肽前体(NT-proBNP)的表达水平,探讨联合检测这两项指标对KD患儿静脉注射免疫球蛋白(IVIG)抵抗及冠状动脉病变(CALs)发生的早期预测价值。

方法

回顾性研究320例1岁以上KD患儿。所有参与者在特定时间采集外周血样本,检测血清铁蛋白和NT-proBNP等实验室指标。根据初始IVIG治疗效果将患者分为IVIG抵抗组和IVIG敏感组。根据心脏超声结果,将患者分为CAL组和非CAL组。采用SPSS 25.0软件进行数据分析。采用受试者操作特征(ROC)曲线评估各指标对KD患者IVIG抵抗和CALs的早期诊断效能。

结果

Logistic回归分析显示,中性粒细胞百分比和初始IVIG治疗前发热持续时间是KD患者IVIG抵抗的独立影响因素。发现IVIG抵抗、初始IVIG治疗前发热持续时间和血清白蛋白水平是CALs的独立影响因素。ROC曲线分析显示,NT-proBNP识别KD患者IVIG抵抗的曲线下面积(AUC)为0.698。当NT-proBNP的截断值为419.6 pg/mL时,对KD患者IVIG抵抗的诊断效能最高,敏感性为81.3%,特异性为53.0%。ROC曲线分析显示,NT-proBNP联合血清铁蛋白识别KD患者CALs的AUC为0.666,对CALs的诊断效率最高。

结论

在1岁以上KD患儿中,NT-proBNP水平可作为IVIG抵抗和CALs的早期预测指标,血清铁蛋白水平可作为CALs的早期预测指标。联合检测NT-proBNP和血清铁蛋白可进一步提高CALs的诊断效能。

相似文献

1
Clinical value of combined detection of serum ferritin and N-terminal pro-brain natriuretic peptide in the assessment of Kawasaki disease in children over 1 year of age.血清铁蛋白与N末端脑钠肽前体联合检测在1岁以上儿童川崎病评估中的临床价值
Ital J Pediatr. 2025 Jul 15;51(1):229. doi: 10.1186/s13052-025-02076-7.
2
Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis.利钠肽对川崎病诊断的有用性:一项系统评价和荟萃分析。
BMJ Open. 2015 Apr 14;5(4):e006703. doi: 10.1136/bmjopen-2014-006703.
3
Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.脑利钠肽和 N 末端脑利钠肽在诊断早产儿血液动力学意义未闭动脉导管中的应用。
Cochrane Database Syst Rev. 2022 Dec 8;12(12):CD013129. doi: 10.1002/14651858.CD013129.pub2.
4
Intravenous immunoglobulin for the treatment of Kawasaki disease.静脉注射免疫球蛋白治疗川崎病。
Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014884. doi: 10.1002/14651858.CD014884.pub2.
5
Predictive Value of Smoking Index Combined with NT-proBNP for Patients with Pulmonary Hypertension Due to Chronic Lung Disease: A Retrospective Study.吸烟指数联合 NT-proBNP 对慢性肺部疾病相关肺动脉高压患者的预测价值:一项回顾性研究。
Int J Chron Obstruct Pulmon Dis. 2024 Jun 4;19:1233-1245. doi: 10.2147/COPD.S448496. eCollection 2024.
6
C-reactive protein to albumin ratio as a prognostic tool for predicting intravenous immunoglobulin resistance in children with kawasaki disease: a systematic review of cohort studies.C-反应蛋白与白蛋白比值作为预测川崎病患儿静脉注射免疫球蛋白抵抗的预后工具:队列研究的系统评价。
Pediatr Rheumatol Online J. 2024 Apr 12;22(1):42. doi: 10.1186/s12969-024-00980-6.
7
Corticosteroids for the treatment of Kawasaki disease in children.用于治疗儿童川崎病的皮质类固醇。
Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD011188. doi: 10.1002/14651858.CD011188.pub2.
8
Clinical prediction of intravenous immunoglobulin-resistant Kawasaki disease based on interpretable Transformer model.基于可解释Transformer模型的静脉注射免疫球蛋白抵抗性川崎病的临床预测
PLoS One. 2025 Jul 9;20(7):e0327564. doi: 10.1371/journal.pone.0327564. eCollection 2025.
9
Predictive value of lymphocyte-to-C-reactive protein ratio for predicting initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease: a prospective cohort study.淋巴细胞与C反应蛋白比值对一大群川崎病患者初始及反复静脉注射免疫球蛋白抵抗的预测价值:一项前瞻性队列研究
Eur J Pediatr. 2025 Jul 9;184(8):472. doi: 10.1007/s00431-025-06296-1.
10
Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis.川崎病冠状动脉并发症及早期干预的重要性:系统评价和荟萃分析。
JAMA Pediatr. 2016 Dec 1;170(12):1156-1163. doi: 10.1001/jamapediatrics.2016.2055.

本文引用的文献

1
Development and validation of a nomogram-based prognostic model to predict coronary artery lesions in Kawasaki disease from 6847 children in China.基于列线图的预测模型的开发与验证:用于预测中国6847例川崎病患儿的冠状动脉病变情况
Comput Methods Programs Biomed. 2025 Mar;260:108588. doi: 10.1016/j.cmpb.2025.108588. Epub 2025 Jan 6.
2
Diagnostic value of syndecan-1 for coronary artery lesions and correlation analysis of laboratory indicators in Kawasaki disease patients.血清透明质酸酶-1 对川崎病患者冠状动脉病变的诊断价值及实验室指标的相关性分析。
Ital J Pediatr. 2024 Oct 9;50(1):209. doi: 10.1186/s13052-024-01772-0.
3
Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki Disease: a retrospective cohort study.
基于 C 反应蛋白水平预测川崎病患儿冠状动脉病变:一项回顾性队列研究。
J Pediatr (Rio J). 2023 Jul-Aug;99(4):406-412. doi: 10.1016/j.jped.2023.02.005. Epub 2023 Mar 25.
4
Serum ferritin as a crucial biomarker in the diagnosis and prognosis of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease: A systematic review and meta-analysis.血清铁蛋白作为川崎病静脉注射免疫球蛋白抵抗和冠状动脉病变诊断及预后的关键生物标志物:一项系统评价和荟萃分析
Front Med (Lausanne). 2022 Aug 10;9:941739. doi: 10.3389/fmed.2022.941739. eCollection 2022.
5
Kawasaki Disease: Pathology, Risks, and Management.川崎病:病理学、风险和管理。
Vasc Health Risk Manag. 2022 Jun 10;18:407-416. doi: 10.2147/VHRM.S291762. eCollection 2022.
6
Global epidemiology of vasculitis.血管炎的全球流行病学。
Nat Rev Rheumatol. 2022 Jan;18(1):22-34. doi: 10.1038/s41584-021-00718-8. Epub 2021 Dec 1.
7
NT-proBNP Response to Heart Failure Therapies: An Imperfect Surrogate.N末端B型利钠肽原对心力衰竭治疗的反应:一个不完美的替代指标。
J Am Coll Cardiol. 2021 Sep 28;78(13):1333-1336. doi: 10.1016/j.jacc.2021.07.045.
8
Serum Ferritin as a Diagnostic Biomarker for Kawasaki Disease.血清铁蛋白作为川崎病的诊断生物标志物。
Ann Lab Med. 2021 May 1;41(3):318-322. doi: 10.3343/alm.2021.41.3.318.
9
Epidemiology of Kawasaki Disease in South Korea: A Nationwide Survey 2015-2017.韩国川崎病的流行病学:2015-2017 年全国调查。
Pediatr Infect Dis J. 2020 Nov;39(11):1012-1016. doi: 10.1097/INF.0000000000002793.
10
JCS/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease.《日本循环学会/日本小儿循环学会2020年川崎病心血管后遗症诊断与管理指南》
Circ J. 2020 Jul 22;84(8):1348-1407. doi: 10.1253/circj.CJ-19-1094. Epub 2020 Jul 8.